Genentech Withdraws Breast Cancer Indication From Tecentriq

moderators

moderators Posts: 9,738

September 2021 edited September 2021 in Stage IV/Metastatic Breast Cancer ONLY

Genentech Withdraws Breast Cancer Indication From Tecentriq
August 28, 2021
On Aug. 27, 2021, Genentech announced it is voluntarily withdrawing the breast cancer indication from the immunotherapy medicine Tecentriq in the United States. Read more...

0

Categories

Join Us on Zoom: Upcoming virtual support groups. Read more...

Share more about you! Fill out your NEW profile.